MRNA Stock Chart & Fundamental Analysis

Fundamentals Charts

About MODERNA INC

Name

MODERNA INC

CEO

Stéphane Bancel

Website

www.modernatx.com

Industry

Healthcare

Year Founded

2010

Employees

4,700

Moderna, Inc. develops and commercializes messenger RNA medicines and vaccines as a biotechnology company in healthcare, with $1.9 billion in revenue in FY2025. Listed on the NASDAQ Global Select Market under MRNA, the company applies its mRNA platform to preventive vaccines as well as therapeutic programs across infectious disease, oncology, and other treatment categories.

Analyst Ratings

Consensus Recommendation

Buy5

Hold2

Sell1

Fundamentals & Financials

Revenue (TTM)

$2.2B

Net Income (TTM)

-$3.1B

EPS (TTM)

-$7.98

ROA (TTM)

-28.75%

Current Ratio

2.29

Dividend Yield

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Item	Q2 FY2026	Q1 FY2026	Q4 FY2025
Revenue	$145,000K	$389,000K	$678,000K
Cost of Sales	$93,000K	$955,000K	$452,000K
Gross Profit	$52,000K	-$566,000K	$226,000K
Operating Income	-$815,000K	-$1,388M	-$857,000K
Net Income	-$782,000K	-$1,343M	-$826,000K
EPS	-$1.96	-$3.4	-$2.11

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings Calendar

Technical Indicators

MODERNA INC's Technical Indicators Summary

The technical picture is mixed, producing a neutral overall stance despite price trading well above its longer-term averages. Momentum indicators diverge: short-term oscillators show overbought readings while CCI and RSI lean positive, and MACD is neutral, so momentum is conflicted. Trend strength is weak, with ADX in low-teens, and ATR shows elevated volatility, which raises the range of possible moves. On-balance volume is sizable and the classic pivot lies below the current price, offering some baseline support. Technical takeaway: upside bias is offset by overbought short-term signals, weak trend strength, and higher volatility.

Buy

5 signals

Neutral

2 signals

Sell

1 signal

Overall: Neutral25% Neutral signals

Indicator	Value	Signal	Explanation
RSI (14)	57.46	Neutral	RSI (57.46) is neutral.
Stochastic %K (14, 3, 3)	92.72	Sell	Stochastic (92.72) > 80, indicating overbought.
CCI (20)	123.14	—	CCI (123.14) > 100, indicating strong upward momentum.
WPR (14)	-0.50	—	Williams %R (-0.50) > -20, indicating overbought.
Momentum (10)	9.25	—	Momentum (9.25) is positive.
MFI	56.41	—	MFI (56.41) is neutral.
MACD Level (12, 26)	-0.59	Neutral	Potential bullish reversal: MACD (-0.59) crossed above signal but is still negative.
Bollinger Bands	$51.92 - $63.83	—	Price is within the bands.
ATR (14)	$3.93 (6.17%)	—	High Volatility (6.17%) suggests increased risk.
ADX (14)	16.15	—	Weak or consolidating trend (ADX < 25). ADX(16.15), +DI(21.25), -DI(17.46)
OBV	270,876,941	—	Bullish volume pressure: OBV is above its 20-day SMA. OBV(270,876,941), 20D-SMA-OBV(257,494,670)
Classic Pivot Point	$60.19	—	Price ($63.74) has broken above resistance R1 ($61.78) — bullish breakout potential.
Fibonacci Pivot Point	$60.19	—	Price ($63.74) has broken above resistance R1 ($61.26) — bullish breakout potential.
Simple Moving Averages	$46.11 - $60.16(5 indicators)	—	SMA group: 5/5 bullish, 0 bearish, 0 neutral. Price above key SMA averages.
Exponential Moving Averages	$46.53 - $59.35(5 indicators)	Buy	EMA group: 5/5 bullish, 0 bearish, 0 neutral. Price above key EMA averages.

Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

The sector is essentially flat at 0.25%, leaving stock-specific drivers in focus. Volume sits on the low side of normal at 0.50×, reflecting modest engagement.

Trading Volume

Below 10d avg (5.5M)

2.7M

vs S&P 500 Today

Strong Outperformance

+5.20%

52-Week Position

Upper range

65.7%

Updated: August 12, 2026 at 16:46 UTC